PT-141 10mg (Research Peptide)

PT-141 (Bremelanotide) is a synthetic peptide analog frequently used in non-clinical research settings to investigate peptide–receptor interactions, signaling behavior, and melanocortin pathway models. Supplied as a lyophilized powder, PT-141 can be incorporated into in vitro and non-clinical experimental designs that focus on receptor binding characteristics and associated downstream responses under controlled conditions. Laboratory work with PT-141 is intended to characterize its behavior as a research compound and does not extend to evaluation of therapeutic effects. The peptide is provided at research-grade purity and stored according to standard peptide handling practices in sealed vials. It is not intended for human use, medical procedures, or any form of supplementation. Referenced research: PT-141 has been described in non-clinical and pharmacology literature that explores melanocortin receptor activity, peptide stability, and signaling in controlled models. Representative publications appear in peptide pharmacology and receptor biology journals. For laboratory research use only. Not for human consumption or therapeutic use.